Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Letter, Love it ... I agree with BaNosser ...
Reply New Message
Back To Forum List View
Letter, Love it

Ometepan
Feb 23, 2007 01:27PM
Re: Letter, Love it over 10 Million shares bought back already - we must

TDAmeritradeStinks
Feb 23, 2007 01:30PM
Re: Letter, Love it

optymystic
Feb 23, 2007 01:34PM
Re: Letter, Love it

Kallister
Feb 23, 2007 01:36PM
Re: Letter, Love it but did you notice Fish did not take stocks?

ignited
Feb 23, 2007 01:41PM
Re: Ignited...I believe Fish will be receiving 3 million in Stock...

ease2002
Feb 23, 2007 01:48PM
Re: Ignited...I believe Fish will be receiving 3 million in Stock...

ignited
Feb 23, 2007 02:03PM
Re: Letter, Love it

BaNosser
Feb 23, 2007 02:05PM
Re: Ignited...

ease2002
Feb 23, 2007 02:08PM
Re: Letter, Love it ... I agree with BaNosser ...

ease2002
Feb 23, 2007 02:21PM
Re: Ignited... thanks ease, hope you are over the flu eom

ignited
Feb 23, 2007 02:26PM
Re: Letter, Love it ... I agree with BaNosser ...

ignited
Feb 23, 2007 02:28PM
Re: Letter, Love it ... I agree with BaNosser ...

optymystic
Feb 23, 2007 02:28PM
Re: Opty ...

ease2002
Feb 23, 2007 02:29PM
Re: Letter, Love it ... I agree with BaNosser ...

moxa1
Feb 23, 2007 02:31PM

Agreed there are positives. This is the pacer filing on Fish. Doesn't designate cash.

http://www.investorshub.com/boards/read_msg.asp?message_id=17229406

 

Re: Opty ... by accident posted ...

ease2002
Feb 23, 2007 02:34PM
Re: Letter, Love it ... I agree with BaNosser ...

moxa1
Feb 23, 2007 02:34PM
Re: Letter, Love it Re: BaNosser:

greeneyes111
Feb 23, 2007 02:41PM
Re: Letter, Love it

Albie
Feb 23, 2007 02:46PM
Re: Letter, Love it Re: BaNosser:

Kallister
Feb 23, 2007 03:01PM
ease, I share your pain. I have the same malady. My body

EDIGOKIE
Feb 23, 2007 03:13PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply